Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7400-7411
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7400
Figure 1
Figure 1 Hepatitis B surface antigen consists of the S protein, M protein (S and preS2 proteins), and L protein (S, preS1, and preS2 proteins). In hepatitis B surface antigen (HBsAg), the preS domain (preS1 + preS2) plays a key role in the human hepatitis B virus (HBV) infection of hepatocytic cells by facilitating HBV attachment and entry, and contains several immunogenic T- and B-cell epitopes. Therefore, the preS domain containing HBV-binding sites and immunogenic epitopes is a diagnostic and therapeutic target or material. In fact, several diagnostic and therapeutic materials and systems based on preS have been developed, including inhibitors of HBV infection, HBV vaccines, diagnostic tools for HBV infection, and hepatocyte-targeting delivery systems for diagnostic and therapeutic molecules.